Gijs van Woerden
Overview
Explore the profile of Gijs van Woerden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crum Y, Hoendermis E, Van Veldhuisen D, van Woerden G, Lobeek M, Dickinson M, et al.
ESC Heart Fail
. 2024 Mar;
11(3):1698-1706.
PMID: 38438270
Aims: Obesity and epicardial adiposity play a role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF), and both are associated with increased filling pressures and reduced exercise...
2.
Hoorntje E, Burns C, Marsili L, Corden B, Parikh V, Meerman G, et al.
Circ Genom Precis Med
. 2022 Dec;
16(1):e003672.
PMID: 36580316
Background: Truncating variants in desmoplakin (tv) are an important cause of arrhythmogenic cardiomyopathy; however the genetic architecture and genotype-specific risk factors are incompletely understood. We evaluated phenotype, risk factors for...
3.
van Woerden G, Van Veldhuisen D, Westenbrink B, de Boer R, Rienstra M, Gorter T
Eur J Heart Fail
. 2022 Nov;
24(12):2238-2250.
PMID: 36394512
Obesity is very common in patients with heart failure with preserved ejection fraction (HFpEF) and it has been suggested that obesity plays an important role in the pathophysiology of this...
4.
van Meijeren A, Ties D, de Koning M, van Dijk R, van Blokland I, Lizana Veloz P, et al.
Int J Cardiol Heart Vasc
. 2022 Apr;
40:101006.
PMID: 35372662
Objective: Increased epicardial adipose tissue (EAT) has been identified as a risk factor for the development of coronary artery disease (CAD). However, the exact role of EAT in the development...
5.
van Veldhuisen S, Gorter T, van Woerden G, de Boer R, Rienstra M, Hazebroek E, et al.
Eur Heart J
. 2022 Mar;
43(20):1955-1969.
PMID: 35243488
Aims: Obesity is a global health problem, associated with significant morbidity and mortality, often due to cardiovascular (CV) diseases. While bariatric surgery is increasingly performed in patients with obesity and...
6.
van Woerden G, Van Veldhuisen D, Gorter T, Ophuis B, Saucedo-Orozco H, van Empel V, et al.
ESC Heart Fail
. 2022 Feb;
9(2):953-957.
PMID: 35146949
Aims: Epicardial adipose tissue (EAT) is increasingly recognized as an important factor in the pathophysiology of heart failure (HF). Cardiac magnetic resonance (CMR) imaging is the gold-standard imaging modality to...
7.
van Woerden G, Van Veldhuisen D, Manintveld O, van Empel V, Willems T, de Boer R, et al.
Circ Heart Fail
. 2021 Dec;
15(3):e009238.
PMID: 34935412
Background: Epicardial adipose tissue (EAT) accumulation is thought to play a role in the pathophysiology of heart failure (HF) with mid-range and preserved ejection fraction, but its effect on outcome...
8.
van Woerden G, Van Veldhuisen D, Gorter T, Willems T, van Empel V, Peters A, et al.
Heart Vessels
. 2021 Jul;
37(2):273-281.
PMID: 34292389
Heart failure (HF) with mid-range or preserved ejection fraction (HFmrEF; HFpEF) is a heterogeneous disorder that could benefit from strategies to identify subpopulations at increased risk. We tested the hypothesis...
9.
van Woerden G, Van Veldhuisen D, Gorter T, van Empel V, Hemels M, Hazebroek E, et al.
Clin Cardiol
. 2021 Jun;
44(7):987-993.
PMID: 34085724
Background: Epicardial adipose tissue (EAT) has been implicated in the pathophysiology of heart failure (HF) with left ventricular ejection fraction (LVEF) >40%, but whether this is due to a regional...
10.
Tromp J, Bryant J, Jin X, van Woerden G, Asali S, Yiying H, et al.
Eur J Heart Fail
. 2021 Mar;
23(5):835-838.
PMID: 33724596
No abstract available.